期刊文献+

The Roles of Four Multi-drug Resistance Proteins in Hepatocellular Carcinoma Multidrug Resistance 被引量:8

The Roles of Four Multi-drug Resistance Proteins in Hepatocellular Carcinoma Multidrug Resistance
下载PDF
导出
摘要 The roles of multi-drug resistance protein 1 (MDR1), multi-drug resistance related protein 1 (MRP1), lung resistance protein (LRP) and breast cancer resistance protein (BCRP) in the multi-drug resistance (MDR) of hepatocellular carcinoma (HCC) were studied. By exposing HepG2 cell line to progressively increased concentrations of adriamycin (ADM), HepG2 multi-drug resistant subline (HepG2/ADM) was induced. The MDR index of HepG2/ADM was detected by using MTT. The expressions of the four MDR proteins in the three cell lines (L02, HepG2, HepG2/ADM) were investigated at mRNA and protein levels by real-time RT-PCR and Western blot respectively. Our results showed that when the ADM concentration was under 100 pg/L, HepG2 could easily be induced to be drug-resistant. The IC50 of the HepG2/ADM to ADM was 282 times that of HepG2. The expression of MDR1 and BCRP mRNA in HepG2/ADM cells were 400 and 9 times that of HepG2 cells respectively while there was no difference in the mRNA expressions of MRPl and LRE There was no difference between HepG2 and L02 cells in the mRNA expressions of the four genes. At the protein level, the expressions of MDRI, BCRP and LRP but MRPl in HepG2/ADM were significantly higher than those of HepG2 and L02. Between HepG2 and L02, there was no difference in the expressions of four genes at the protein level. HepG2/ADM is a good model for the study of MDR. The four genes are probably the normally expressed gene in liver. The expressions of MDRl and BCRP could be up-regulated by anti-cancer agents in vitro. The MDR of HCC was mainly due to the up-regulation of MDR1 and BCRP but MRP1 and LRE These findings suggest they may serve as targets for the reversal of MDR of HCC. The roles of multi-drug resistance protein 1 (MDR1), multi-drug resistance related protein 1 (MRP1), lung resistance protein (LRP) and breast cancer resistance protein (BCRP) in the multi-drug resistance (MDR) of hepatocellular carcinoma (HCC) were studied. By exposing HepG2 cell line to progressively increased concentrations of adriamycin (ADM), HepG2 multi-drug resistant subline (HepG2/ADM) was induced. The MDR index of HepG2/ADM was detected by using MTT. The expressions of the four MDR proteins in the three cell lines (L02, HepG2, HepG2/ADM) were investigated at mRNA and protein levels by real-time RT-PCR and Western blot respectively. Our results showed that when the ADM concentration was under 100 pg/L, HepG2 could easily be induced to be drug-resistant. The IC50 of the HepG2/ADM to ADM was 282 times that of HepG2. The expression of MDR1 and BCRP mRNA in HepG2/ADM cells were 400 and 9 times that of HepG2 cells respectively while there was no difference in the mRNA expressions of MRPl and LRE There was no difference between HepG2 and L02 cells in the mRNA expressions of the four genes. At the protein level, the expressions of MDRI, BCRP and LRP but MRPl in HepG2/ADM were significantly higher than those of HepG2 and L02. Between HepG2 and L02, there was no difference in the expressions of four genes at the protein level. HepG2/ADM is a good model for the study of MDR. The four genes are probably the normally expressed gene in liver. The expressions of MDRl and BCRP could be up-regulated by anti-cancer agents in vitro. The MDR of HCC was mainly due to the up-regulation of MDR1 and BCRP but MRP1 and LRE These findings suggest they may serve as targets for the reversal of MDR of HCC.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2007年第2期173-175,共3页 华中科技大学学报(医学英德文版)
基金 This project was supported by a grant from the Foundation for Key Scientific Research Programs of Ministry of Health of China (No. 20012003)
关键词 multi-drug resistance HCC MDRI BCRP LRP MRPI multi-drug resistance HCC MDRI BCRP LRP MRPI
  • 相关文献

参考文献10

  • 1Suvannasankha A,Minderman H,O’Loughlin K L et al.Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function[].Leukemia.2004
  • 2Volk E L,Farley K M,Wu Y et al.Overexpression of wild-type breast cancer resistance protein mediates meth- otrexate resistance[].Cancer Research.2002
  • 3Uggla B,Stahl E,Wagsater D et al.BCRP mRNA expres- sion v.clinical outcome in 40 adult AML patients[].Leukemia Research.2005
  • 4Abbott B L,Colapietro A M,Barnes Y et al.Low levels of ABCG2 expression in adult AML blast samples[].Blood.2002
  • 5Kowalski P,Stein U,Scheffer G L et al.Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2[].Cancer Gene Therapy.2002
  • 6Brugger D,Brischwein K,Liu C et al.Induction of drug resistance and protein kinase C genes in A2780 ovarian cancer cells after incubation with antineoplastic agents at sublethal concentrations[].Anticancer Research.2002
  • 7Ding L,Chen X P,Zhang Z W et al.Study on the mecha- nism of reversing multidrug resistance of hepatocarci- noma by bromocriptine[].Chinese Journal of Hepatology.2006
  • 8Tahara H,Kusuhara H,Fuse E et al.P-glycoprotein plays a major role in the efflux of fexofenadine in the small in- testine and blood-brain barrier, but only a limited role in its biliary excretion[].Drug Metabolism and Disposition.2005
  • 9Doyle L A,Yang W,Abruzzo L V et al.A multidrug resis- tance transporter from human MCF-7 breast cancer cells[].Proceedings of the National Academy of Sciences of the United States of America.1998
  • 10Merino G,van Herwaarden A E,Wagenaar E et al.Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver[].Molecular Pharmacology.2005

同被引文献50

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部